Next Article in Journal
Prevalence and Genetic Characterisation of Human Sapovirus from Children with Diarrhoea in the Rural Areas of Vhembe District, South Africa, 2017–2020
Next Article in Special Issue
Discovery of RSV-Induced BRD4 Protein Interactions Using Native Immunoprecipitation and Parallel Accumulation—Serial Fragmentation (PASEF) Mass Spectrometry
Previous Article in Journal
Isolation and Characterization of Cross-Reactive Human Monoclonal Antibodies That Potently Neutralize Australian Bat Lyssavirus Variants and Other Phylogroup 1 Lyssaviruses
Previous Article in Special Issue
Alternative mRNA Processing of Innate Response Pathways in Respiratory Syncytial Virus (RSV) Infection
Article

SARS-CoV-2 Variant of Concern 202012/01 Has about Twofold Replicative Advantage and Acquires Concerning Mutations

1
Institute of Fundamental Technological Research, Polish Academy of Sciences, 02-106 Warsaw, Poland
2
Inter-Faculty Individual Studies in Mathematics and Natural Sciences, The MISMaP College, University of Warsaw, 02-097 Warsaw, Poland
3
Faculty of Mathematics, Informatics and Mechanics, University of Warsaw, 02-097 Warsaw, Poland
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Academic Editor: Allan Brasier
Viruses 2021, 13(3), 392; https://doi.org/10.3390/v13030392
Received: 13 January 2021 / Revised: 19 February 2021 / Accepted: 24 February 2021 / Published: 1 March 2021
The novel SARS-CoV-2 Variant of Concern (VOC)-202012/01 (also known as B.1.1.7), first collected in United Kingdom on 20 September 2020, is a rapidly growing lineage that in January 2021 constituted 86% of all SARS-CoV-2 genomes sequenced in England. The VOC has been detected in 40 out of 46 countries that reported at least 50 genomes in January 2021. We have estimated that the replicative advantage of the VOC is in the range 1.83–2.18 [95% CI: 1.71–2.40] with respect to the 20A.EU1 variant that dominated in England in November 2020, and in range 1.65–1.72 [95% CI: 1.46–2.04] in Wales, Scotland, Denmark, and USA. As the VOC strain will likely spread globally towards fixation, it is important to monitor its molecular evolution. We have estimated growth rates of expanding mutations acquired by the VOC lineage to find that the L18F substitution in spike has initiated a fast growing VOC substrain. The L18F substitution is of significance because it has been found to compromise binding of neutralizing antibodies. Of concern are immune escape mutations acquired by the VOC: E484K, F490S, S494P (in the receptor binding motif of spike) and Q677H, Q675H (in the proximity of the polybasic cleavage site at the S1/S2 boundary). These mutants may hinder efficiency of existing vaccines and expand in response to the increasing after-infection or vaccine-induced seroprevalence. View Full-Text
Keywords: COVID-19 pandemic; SARS-CoV-2; spike protein; VOC-202012/01; spike L18F; genome sequencing; mutation COVID-19 pandemic; SARS-CoV-2; spike protein; VOC-202012/01; spike L18F; genome sequencing; mutation
Show Figures

Figure 1

MDPI and ACS Style

Grabowski, F.; Preibisch, G.; Giziński, S.; Kochańczyk, M.; Lipniacki, T. SARS-CoV-2 Variant of Concern 202012/01 Has about Twofold Replicative Advantage and Acquires Concerning Mutations. Viruses 2021, 13, 392. https://doi.org/10.3390/v13030392

AMA Style

Grabowski F, Preibisch G, Giziński S, Kochańczyk M, Lipniacki T. SARS-CoV-2 Variant of Concern 202012/01 Has about Twofold Replicative Advantage and Acquires Concerning Mutations. Viruses. 2021; 13(3):392. https://doi.org/10.3390/v13030392

Chicago/Turabian Style

Grabowski, Frederic, Grzegorz Preibisch, Stanisław Giziński, Marek Kochańczyk, and Tomasz Lipniacki. 2021. "SARS-CoV-2 Variant of Concern 202012/01 Has about Twofold Replicative Advantage and Acquires Concerning Mutations" Viruses 13, no. 3: 392. https://doi.org/10.3390/v13030392

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop